---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-000235"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2026-01-05T23:59:59+00:00"
generated_at: "2026-05-16T11:46:25.440034+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Medifast CBOO Tyree departs Dec 31; COO Johnson promoted to President; CEO Chard to non-exec Chairman June 1, 2026

## Summary
- Anthony Tyree (CBOO) departs Dec 31, 2025; receives $706,984 severance (salary + target bonus).
- Nicholas Johnson promoted from Chief Field Operations Officer to President, effective Jan 5, 2026.
- CEO Daniel Chard to transition to non-executive Chairman effective June 1, 2026; salary cut from $1M to $800K.
- Chard's target bonus reduced from 115% to 100% and LTI from $4.6M to $2.4M until transition.
- CFO James Maloney assumes leadership of supply chain function.

## SEC filing metadata
- accession: 0001628280-26-000235
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2026-01-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828026000235/0001628280-26-000235-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828026000235/med-20251230.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-000235
- JSON: https://secwatch.observer/filing/0001628280-26-000235.json
- Plain text: https://secwatch.observer/filing/0001628280-26-000235.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.